These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26458382)

  • 21. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy.
    Leon CA; Raij L
    J Hypertens; 2005 Nov; 23(11):1931-7. PubMed ID: 16208129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
    Berthier CC; Zhang H; Schin M; Henger A; Nelson RG; Yee B; Boucherot A; Neusser MA; Cohen CD; Carter-Su C; Argetsinger LS; Rastaldi MP; Brosius FC; Kretzler M
    Diabetes; 2009 Feb; 58(2):469-77. PubMed ID: 19017763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B; Saraf M
    J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of AGEs in diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily Low-intensity Pulsed Ultrasound Ameliorates Renal Fibrosis and Inflammation in Experimental Hypertensive and Diabetic Nephropathy.
    Aibara Y; Nakashima A; Kawano KI; Yusoff FM; Mizuki F; Kishimoto S; Kajikawa M; Maruhashi T; Higashi Y
    Hypertension; 2020 Dec; 76(6):1906-1914. PubMed ID: 33131306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.
    Tanase DM; Gosav EM; Anton MI; Floria M; Seritean Isac PN; Hurjui LL; Tarniceriu CC; Costea CF; Ciocoiu M; Rezus C
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.
    Warren AM; Knudsen ST; Cooper ME
    Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867
    [No Abstract]   [Full Text] [Related]  

  • 31. Current update in the management of diabetic nephropathy.
    Van Buren PN; Toto R
    Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway.
    Al-Qabbaa SM; Qaboli SI; Alshammari TK; Alamin MA; Alrajeh HM; Almuthnabi LA; Alotaibi RR; Alonazi AS; Bin Dayel AF; Alrasheed NM; Alrasheed NM
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic nephropathy: A potential savior with 'rotten-egg' smell.
    Dugbartey GJ
    Pharmacol Rep; 2017 Apr; 69(2):331-339. PubMed ID: 28183033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
    Harlan SM; Heinz-Taheny KM; Sullivan JM; Wei T; Baker HE; Jaqua DL; Qi Z; Cramer MS; Shiyanova TL; Breyer MD; Heuer JG
    J Am Soc Nephrol; 2018 Feb; 29(2):477-491. PubMed ID: 29061652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.
    Yamagishi S; Fukami K; Ueda S; Okuda S
    Curr Drug Targets; 2007 Aug; 8(8):952-9. PubMed ID: 17691932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress in early diabetic nephropathy: fueling the fire.
    Singh DK; Winocour P; Farrington K
    Nat Rev Endocrinol; 2011 Mar; 7(3):176-84. PubMed ID: 21151200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β: the connecting link between nephropathy and fibrosis.
    Sutariya B; Jhonsa D; Saraf MN
    Immunopharmacol Immunotoxicol; 2016; 38(1):39-49. PubMed ID: 26849902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Future: Experimental Therapies for Renal Disease in Diabetes.
    Fouli GE; Gnudi L
    Nephron; 2019; 143(1):3-7. PubMed ID: 30257247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic nephropathy: pathogenesis and treatment.
    Adler S; Nast C; Artishevsky A
    Annu Rev Med; 1993; 44():303-15. PubMed ID: 8476252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.